about
Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response.Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.Bilateral persistent fetal vasculature due to a mutation in the Norrie disease protein gene.Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation.Fanconi anemia: correlating central nervous system malformations and genetic complementation groups.Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients.The role of percutaneous embolization techniques in the management of dural sinus malformations with atypical angioarchitecture in neonates: report of 2 cases.Endovascular management of a vein of Galen aneurysmal malformation in an infant with challenging femoral arterial access.Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes.Childhood cerebral X-linked adrenoleukodystrophy: diffusion tensor imaging measurements for prediction of clinical outcome after hematopoietic stem cell transplantation.Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.Potentially reversible acute cerebellar toxicity associated with Minnelide.Various Cranial and Orbital Imaging Findings in Pediatric Abusive and Non-abusive Head trauma, and Relation to Outcomes.Infantile Epileptic Encephalopathy Associated With SCN2A Mutation Responsive to Oral Mexiletine.Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy.Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report.Septo-optic Dysplasia : Assessment of Associated Findings with Special Attention to the Olfactory Sulci and TractsSurvival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell TransplantationBevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and ToxicitiesSuccessful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophyAssociation between APOE4 and biomarkers in cerebral adrenoleukodystrophy.MR imaging findings in the reticular formation in siblings with MPV17-related mitochondrial depletion syndromeOutcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort reportCerebellar superficial siderosis of chronic subarachnoid hemorrhage in a patient with Tacrolimus-associated posterior reversible encephalopathyEffect of patient positioning on cerebrospinal fluid opening pressureTransforaminal Lumbar Puncture: An Alternative Technique in Patients with Challenging AccessVascular Channel Mimicking a Skull FracturePseudo-Leptomeningeal Contrast Enhancement at 3T in Pediatric Patients Sedated by PropofolCerebral adrenoleukodystrophy is associated with loss of tolerance to profilinEffectiveness of alternative routes of intra-arterial chemotherapy administration for retinoblastoma: Potential for response and complicationsHypothalamic hamartomas and inner ear diverticula with X-linked stapes gusher syndrome - new associations?
P50
Q33606132-9CAE8DAE-1BEF-4FFE-BA18-DBE8884BA42AQ34491461-68EAC038-122D-416C-8D20-9E7BF8DDDC5CQ36589668-41D63BC3-734F-46A2-AF13-F1CD12D281A4Q37246713-7541CC1B-0AB8-4BF2-B5F5-BFDC7C51BFF0Q39173536-EE64458B-85EA-4812-AF56-7C6C0C225238Q39679149-9EC2D47A-166B-4C2C-B47F-B0E86683B055Q40275432-2C8E1513-B0CB-4868-9F23-367C8E129406Q40365229-27501317-5FE2-43BC-BA23-935B5ACD18C3Q42738690-8C4D075F-234D-4DA0-8CE5-12D643F284DAQ44038366-6EF5795A-6679-4EA9-918C-BBB3C62F9858Q47392381-DF3EEB40-7B66-4E55-BB60-DD2E89967C09Q48112977-DDBE9B6D-D93C-4602-86B4-08F5C5EA17E4Q48179843-F9663391-AEF0-4E1A-AC15-1EB4B703A62FQ51314749-FD7D1E5F-8FBE-48E4-9CBF-A1B76D4A0868Q55042989-664D7FAA-82BF-42D3-AB6F-EB2D68E4E48DQ55332326-6DD85BCF-D94A-4C7A-830B-CDD454162E5FQ56232634-8D56221B-0E95-49E9-8216-714588C08A13Q57186056-6F6F75F3-6914-4ED2-8555-C12AB2E019F3Q58098113-BDBCB5D7-2426-4F61-A286-EF2A31E2323CQ64064131-9A560B89-AD07-4DAB-AB75-2A528338D854Q64882275-364FCD64-B348-4F54-B033-B0BE7AF0D59EQ83929210-27053F54-ECCD-4D6E-B009-1E812584E756Q84132044-CDBC2072-3DEA-4598-AE94-8B4D90D99E3AQ85909677-EC5B15F4-B764-480F-A976-EA79307DFFECQ86697581-5439FAAB-6729-48E5-8CE5-40E23DE31476Q88137531-9B57FF75-8193-4139-B44F-7E327BD98301Q88782573-3F42E2B9-803B-4076-9791-8BAAF81B7B5BQ90519159-2A83965F-526F-4B0B-898C-56019A278683Q92096586-C0DE1F2C-1F0A-405A-87AC-9356770F78DAQ92736782-11EDE16B-76ED-4CB8-9E24-D5C46E9D3225Q92804899-A678500F-B56F-4EAB-8597-EC7D86E367CD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David R Nascene
@ast
David R Nascene
@en
David R Nascene
@es
David R Nascene
@nl
type
label
David R Nascene
@ast
David R Nascene
@en
David R Nascene
@es
David R Nascene
@nl
prefLabel
David R Nascene
@ast
David R Nascene
@en
David R Nascene
@es
David R Nascene
@nl
P106
P1153
9242609300
P21
P31
P496
0000-0002-2468-7359